With over 10 years of experience in pharmacokinetic and immunogenicity testing, and over 30 years in the biomarker business, Nexelis is an immunology-driven partner of choice for the development, qualification and validation of in vivo models, immunology assays, and sample testing to support large molecule development.
With our team of experts, our innovative technology platforms and state-of-the-art laboratories, we specialize in multiple clinical immunology services, providing support for clinical development for large molecules and biomarkers studies. We also offer custom solutions (immune or efficacy readouts) for in vivo proof-of-concept adapted to biologically-active, large molecules.
We have established a menu of over 150 biomarkers, featuring over 90% which are analytically validated, and can be leveraged based on your needs, to reduce the time and cost needed for drug development. We can partner with you from feasibility to full validation and co-develop companion or complimentary diagnostic biomarkers.
We have a wide range of expertise across various biomarker panels covering immunology and non-immunology-related diseases or injuries:
- Inflammatory cytokine and chemokine
- Organ injury panels (liver, kidney)
- Angiogenesis biomarkers
- Tumor antigens
- And many more…